Literature DB >> 23322298

The SCF-Fbw7 ubiquitin ligase degrades MED13 and MED13L and regulates CDK8 module association with Mediator.

Michael A Davis1, Elizabeth A Larimore, Brian M Fissel, Jherek Swanger, Dylan J Taatjes, Bruce E Clurman.   

Abstract

The Mediator complex is an essential transcription regulator that bridges transcription factors with RNA polymerase II. This interaction is controlled by dynamic interactions between Mediator and the CDK8 module, but the mechanisms governing CDK8 module-Mediator association remain poorly understood. We show that Fbw7, a tumor suppressor and ubiquitin ligase, binds to CDK8-Mediator and targets MED13/13L for degradation. MED13/13L physically link the CDK8 module to Mediator, and Fbw7 loss increases CDK8 module-Mediator association. Our work reveals a novel mechanism regulating CDK8 module-Mediator association and suggests an expanded role for Fbw7 in transcriptional control and an unanticipated relationship with the CDK8 oncogene.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322298      PMCID: PMC3566307          DOI: 10.1101/gad.207720.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  34 in total

1.  Activator-Mediator binding regulates Mediator-cofactor interactions.

Authors:  Christopher C Ebmeier; Dylan J Taatjes
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-04       Impact factor: 11.205

Review 2.  The human Mediator complex: a versatile, genome-wide regulator of transcription.

Authors:  Dylan J Taatjes
Journal:  Trends Biochem Sci       Date:  2010-03-17       Impact factor: 13.807

3.  Large-scale proteomics analysis of the human kinome.

Authors:  Felix S Oppermann; Florian Gnad; Jesper V Olsen; Renate Hornberger; Zoltán Greff; György Kéri; Matthias Mann; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2009-04-15       Impact factor: 5.911

4.  The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.

Authors:  Ning Liu; Hui Li; Shuangxi Li; Mingyue Shen; Ning Xiao; Yunfei Chen; Yan Wang; Weichao Wang; Rui Wang; Qian Wang; Jianhua Sun; Ping Wang
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

5.  F-box and WD repeat domain-containing 7 regulates intestinal cell lineage commitment and is a haploinsufficient tumor suppressor.

Authors:  Rocio Sancho; Anett Jandke; Hayley Davis; Markus E Diefenbacher; Ian Tomlinson; Axel Behrens
Journal:  Gastroenterology       Date:  2010-06-02       Impact factor: 22.682

6.  Defining the human deubiquitinating enzyme interaction landscape.

Authors:  Mathew E Sowa; Eric J Bennett; Steven P Gygi; J Wade Harper
Journal:  Cell       Date:  2009-07-16       Impact factor: 41.582

7.  CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity.

Authors:  Ron Firestein; Adam J Bass; So Young Kim; Ian F Dunn; Serena J Silver; Isil Guney; Ellen Freed; Azra H Ligon; Natalie Vena; Shuji Ogino; Milan G Chheda; Pablo Tamayo; Stephen Finn; Yashaswi Shrestha; Jesse S Boehm; Supriya Jain; Emeric Bojarski; Craig Mermel; Jordi Barretina; Jennifer A Chan; Jose Baselga; Josep Tabernero; David E Root; Charles S Fuchs; Massimo Loda; Ramesh A Shivdasani; Matthew Meyerson; William C Hahn
Journal:  Nature       Date:  2008-09-14       Impact factor: 49.962

Review 8.  The Fbxw7/hCdc4 tumor suppressor in human cancer.

Authors:  YingMeei Tan; Olle Sangfelt; Charles Spruck
Journal:  Cancer Lett       Date:  2008-06-09       Impact factor: 8.679

Review 9.  Revving the Throttle on an oncogene: CDK8 takes the driver seat.

Authors:  Ron Firestein; William C Hahn
Journal:  Cancer Res       Date:  2009-10-06       Impact factor: 12.701

10.  CDK8 is a positive regulator of transcriptional elongation within the serum response network.

Authors:  Aaron J Donner; Christopher C Ebmeier; Dylan J Taatjes; Joaquín M Espinosa
Journal:  Nat Struct Mol Biol       Date:  2010-01-24       Impact factor: 15.369

View more
  61 in total

Review 1.  Programmed Cell Death Initiation and Execution in Budding Yeast.

Authors:  Randy Strich
Journal:  Genetics       Date:  2015-08       Impact factor: 4.562

Review 2.  Muscle as a "mediator" of systemic metabolism.

Authors:  Kedryn K Baskin; Benjamin R Winders; Eric N Olson
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

3.  A comprehensive method for detecting ubiquitinated substrates using TR-TUBE.

Authors:  Yukiko Yoshida; Yasushi Saeki; Arisa Murakami; Junko Kawawaki; Hikaru Tsuchiya; Hidehito Yoshihara; Mayumi Shindo; Keiji Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

4.  Redefining the MED13L syndrome.

Authors:  Abidemi Adegbola; Luciana Musante; Bert Callewaert; Patricia Maciel; Hao Hu; Bertrand Isidor; Sylvie Picker-Minh; Cedric Le Caignec; Barbara Delle Chiaie; Olivier Vanakker; Björn Menten; Annelies Dheedene; Nele Bockaert; Filip Roelens; Karin Decaestecker; João Silva; Gabriela Soares; Fátima Lopes; Hossein Najmabadi; Kimia Kahrizi; Gerald F Cox; Steven P Angus; John F Staropoli; Ute Fischer; Vanessa Suckow; Oliver Bartsch; Andrew Chess; Hans-Hilger Ropers; Thomas F Wienker; Christoph Hübner; Angela M Kaindl; Vera M Kalscheuer
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

5.  Ubiquitylation: Mediation by degradation.

Authors:  Nicola McCarthy
Journal:  Nat Rev Cancer       Date:  2013-01-31       Impact factor: 60.716

6.  The FBW7-KLF2 axis regulates endothelial functions.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Cell Res       Date:  2013-04-09       Impact factor: 25.617

7.  Cyclin-dependent kinase 8 module expression profiling reveals requirement of mediator subunits 12 and 13 for transcription of Serpent-dependent innate immunity genes in Drosophila.

Authors:  Emilia Kuuluvainen; Heini Hakala; Essi Havula; Michelle Sahal Estimé; Mika Rämet; Ville Hietakangas; Tomi P Mäkelä
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

Review 8.  Control of Muscle Metabolism by the Mediator Complex.

Authors:  Leonela Amoasii; Eric N Olson; Rhonda Bassel-Duby
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

10.  MED12 Regulates HSC-Specific Enhancers Independently of Mediator Kinase Activity to Control Hematopoiesis.

Authors:  Beatriz Aranda-Orgilles; Ricardo Saldaña-Meyer; Eric Wang; Eirini Trompouki; Anne Fassl; Stephanie Lau; Jasper Mullenders; Pedro P Rocha; Ramya Raviram; María Guillamot; María Sánchez-Díaz; Kun Wang; Clarisse Kayembe; Nan Zhang; Leonela Amoasii; Avik Choudhuri; Jane A Skok; Markus Schober; Danny Reinberg; Piotr Sicinski; Heinrich Schrewe; Aristotelis Tsirigos; Leonard I Zon; Iannis Aifantis
Journal:  Cell Stem Cell       Date:  2016-08-25       Impact factor: 24.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.